Françoise Baylis is University Research Professor at Dalhousie University. Prior to this, she was Canada Research Chair in Bioethics and Philosophy from 2004-2018. She is a member of the Order of Canada and the Order of Nova Scotia, as well as a Fellow of the Royal Society of Canada and a Fellow of the Canadian Academy of Health Sciences. In 2017 she was awarded the Canadian Bioethics Society Lifetime Achievement Award for her contributions to bioethics research, education, and outreach to policymakers and publics.
Baylis is a philosopher whose innovative work in bioethics, at the intersection of policy and practice, has stretched the boundaries of the field. Her work challenges us to think broadly and deeply about the direction of health, science and biotechnology. It aims to move the limits of mainstream bioethics and develop more effective ways to understand and tackle public policy challenges.
A public intellectual for the modern age, Baylis brings her ethical sensibilities, informed by best practices, theory and common sense, to a wide range of issues. Her current research focuses on human genome modification, assisted human reproduction, research involving women, and public health ethics with a focus COVID-19.
Baylis is the author of Altered Inheritance: CRISPR and the Ethics of Human Genome Editing. Currently, she is a member of the WHO Working Group on Principles of the Global Guidance Framework for the Responsible Use of the Life Sciences and of the Royal Society of Canada Committee on Public Engagement. She is also a member of the organizing committee for the Third International Summit on Human Genome Editing.